tiprankstipranks
Avadel Pharmaceuticals sees Q4 revenue $50M, consensus $52.7M
The Fly

Avadel Pharmaceuticals sees Q4 revenue $50M, consensus $52.7M

The company said, “Fourth quarter revenue was impacted by approximately $6.0 million due to an estimated 1.5 fewer weeks of inventory in the channel at December 31, 2024, compared to September 30, 2024.”

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App